Blue Note Therapeutics: Improving Mental Health in Cancer Care
Cancer is a difficult disease to treat and manage. There are over 100 types of cancer in the world, and each case presents its own unique challenges — stage and severity, unique patient needs, treatment response, and so on. Medical professionals work to provide the best care possible, but treatment can take its toll.
Beyond the physical discomfort of treatment — chemotherapy, surgeries, related physical therapy, etc. — there is also significant mental distress associated for cancer patients. The mental and emotional distress of cancer and treatment (such as anxiety or depression) adversely impact health outcomes and increase healthcare utilization and costs.
Alumni Ventures (AV) portfolio company Blue Note Therapeutics is providing patients a novel solution for mental health support in cancer care. Leveraging Prescription Digital Therapeutics, the company seeks to improve outcomes through decreasing psychological distress, strengthening immune function, and improving treatment adherence.
Blue Note digitizes clinically proven, cancer-specific, face-to-face interventions from top cancer centers to create therapeutic software that helps ease anxiety and depression associated with a cancer diagnosis. To learn more about Blue Note’s platform and what AV likes about the company, click below.
Alumni Ventures (AV) provides smart, simple venture portfolios to accredited individuals. PitchBook listed AV as the third most active VC firm in the U.S. in 2021.
